一项左旋多巴乙酯对伴有运动波动帕金森病患者疗效的随机对照试验

来源 :世界核心医学期刊文摘(神经病学分册) | 被引量 : 0次 | 上传用户:yanlian2008
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background: Motor fluctuations are a common complication in patients with Parkinson disease (PD) receiving long-term levodopa therapy. Slowed gastric emptying and poor solubility of levodopa in the gastrointestinal tract may delay the onset of drug benefit after dosing. Etilevodopa is an ethylester prodrug of levodopa that has greater gastric solubility, passes quickly into the sm all intestine, is rapidly hydrolyzed to levodopa, and has a shortened time to ma ximum levodopa concentration. Objective: To determine the efficacy, safety, and tolerability of etilevodopa in patients with PD who have motor fluctuations. Des ign: A double-blind, randomized, comparative clinical trial. Setting: Forty-four sites in the United States and Canada. Patients: Three hundred twenty-seven patients with PD who had a latency of at least 90 minutes total daily time to “on”(TTON) after levodopa dosing. Intervention: Treatment with either etilevodop a-carbidopa or levodopa-carbidopa for 18 weeks. Main Outcome Measure: Change from baseline in total daily TTON as measured using home diaries. Results: The reduction in mean total daily TTON from baseline to treatment was 0.58 hour in the etilevodopa-carbidopa group and 0.79 hour in the levodopa-carbidopa group (P=.24). There was no significant difference between the etilevodopacarbidopa and levodopa-carbidopa groups in the reduction of response failures (-6.82%vs -4.69%; P=.20). Total daily “off ”time improved in the etilevodopa-car-bidopa (-0.85 hour) and levodopa-carbidopa (-0.87 hour) groups without an increase in on time with troublesome dyskinesias. Conclusion: Despite the theoret ical pharmacokinetic advantage of etilevodopa, there was no improvement in TTON, response failures, or off time compared with levodopa. Background: Motor fluctuations are a common complication in patients with Parkinson disease (PD) receiving long-term levodopa therapy. Slowed gastric emptying and poor solubility of levodopa in the gastrointestinal tract may delay the onset of drug benefit after dosing. Etilevodopa is an ethylester prodrug of levodopa that has greater methyl alcohol concentration, rapidly transmited to levodopa, and has a shortened time to ma ximum levodopa concentration. Objective: To determine the efficacy, safety, and tolerability of etilevodopa in patients with PD Forty-four sites in the United States and Canada. Patients: Three hundred twenty-seven patients with PD who had a latency of at least 90 minutes total daily time to “on” (TTON) after levodopa dosing. Intervention: Treatment with either etilevodop a-carbidopa or levodopa-carbidopa for 18 weeks. Main O utcome Measure: Change from baseline in total daily TTON as measured using home diaries. Results: The reduction in mean total daily TTON from baseline to treatment was 0.58 hour in the etilevodopa-carbidopa group and 0.79 hour in the levodopa-carbidopa group (P = .24). There was no significant difference between the etilevodopacarbidopa and levodopa-carbidopa groups in the reduction of response failures (-6.82% vs -4.69%; P = .20). Total daily “off” time improved in the etilevodopa-car -bidopa (-0.85 hour) and levodopa-carbidopa (-0.87 hour) groups without an increase in on time with troublesome dyskinesias. Conclusion: Despite the theoret ical pharmacokinetic advantage of etilevodopa, there was no improvement in TTON, response failures, or off time compared with levodopa.
其他文献
高职教育是我国高等教育的重要组成部分,为社会培养了大量的应用型技术人才和高素质劳动者。但是,受各种因素的制约,我国的高职教育在定位和特色方面不突出,在技术人才培养的
岁末年初,总是让人想得很多,尤其是在当下国际政治,经济局势复杂多变的背景下,当国内的经济发展正处于从高速到减速的变速过程中,中央经济工作会议“稳中求进”的定调让很多人心里踏实了很多,可以说“稳”不仅“稳”在经济发展,更“稳”在社会,民心和信心。  稳不是保守和一成不变,而是从注重经济发展速度到注重经济发展质量的一种调整和转变,这是一种明智。高增长,保增长是一段时期把握发展时机所要求的提速的需要,而
中国南方地区稀土矿的开采对当地的生态环境和农业产生了极大的影响,因此,本文选取稀土矿区周边典型水稻土,研究了稀土元素在土壤-水稻中的生物迁移和积累特征.结果表明,土壤
背景:透明质酸和活性玻璃都是应用于创伤修复的生物材料,先前查寻的报道主要为二者单方面的实验结果。目的:拟验证不同配方活性玻璃与透明质酸复合凝胶在大鼠创面修复中的作